OTTMUSG00000010432 inhibitors are a class of chemical compounds specifically designed to target and block the activity of the protein encoded by the gene OTTMUSG00000010432, identified through mouse genomic research. Though the specific function of this gene may not yet be fully detailed, proteins encoded by genes of this nature often play pivotal roles in fundamental cellular processes, such as intracellular signaling, transcriptional regulation, or metabolic pathways. Inhibitors of OTTMUSG00000010432 work by either preventing the protein from binding to its natural substrates, disrupting its interaction with other cellular components, or hindering its involvement in specific enzymatic processes. This disruption halts the normal downstream activities influenced by the protein, offering researchers an opportunity to study the role of this gene in cellular regulation.
The investigation of OTTMUSG00000010432 inhibitors provides significant insight into the molecular functions of this gene and its encoded protein. By inhibiting its activity, scientists can observe how blocking this protein affects broader cellular networks, such as signaling pathways, gene expression modulation, or protein-protein interactions that are essential for maintaining cellular stability. Additionally, studying the effects of these inhibitors helps to unravel the protein's contribution to maintaining homeostasis and its role in complex regulatory mechanisms within the cell. By exploring how the inhibition of OTTMUSG00000010432 alters cellular behavior, researchers can gain a clearer understanding of how this protein integrates with other molecular pathways and how its regulation is vital for the overall functioning of the cell.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin, an mTOR inhibitor, may affect protein synthesis pathways, potentially influencing LOC100041077 isoform X1. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $47.00 $145.00 | 51 | |
Dasatinib, a tyrosine kinase inhibitor, could affect signaling pathways related to cell growth, impacting LOC100041077 isoform X1. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
U0126, inhibiting MEK1/2, may affect the MAPK/ERK pathway, potentially impacting LOC100041077 isoform X1. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580, a p38 MAP kinase inhibitor, may influence stress response pathways, affecting LOC100041077 isoform X1. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002, inhibiting PI3K, could affect cell survival pathways, impacting LOC100041077 isoform X1. | ||||||
WZ 4002 | 1213269-23-8 | sc-364655 sc-364655A | 10 mg 50 mg | $180.00 $744.00 | 1 | |
WZ4002, an EGFR inhibitor, could influence signaling processes involving LOC100041077 isoform X1. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $56.00 $260.00 $416.00 | 129 | |
Sorafenib, a multikinase inhibitor, could impact VEGFR and PDGFR pathways, affecting LOC100041077 isoform X1. | ||||||
Nilotinib | 641571-10-0 | sc-202245 sc-202245A | 10 mg 25 mg | $205.00 $405.00 | 9 | |
Nilotinib, inhibiting BCR-ABL, may modulate oncogenic signaling, impacting LOC100041077 isoform X1. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059, an MEK inhibitor, could impact the MAPK pathway, potentially influencing LOC100041077 isoform X1. | ||||||
Sunitinib, Free Base | 557795-19-4 | sc-396319 sc-396319A | 500 mg 5 g | $150.00 $920.00 | 5 | |
Sunitinib, a kinase inhibitor, may influence angiogenesis pathways, impacting LOC100041077 isoform X1. |